ArticleInorganic chemistry2025
Secondary Phosphines Bearing N-Heterocyclic Imine Groups: Polarity Umpolung of Highly Electron-Rich P-H Bonds.
Article in Inorganic chemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Bis(phosphazenyl)phosphines: From Superbases to Superhydrides.Molecules (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The synthesis and reactivity of secondary phosphines carrying two N-heterocyclic imine substituents are reported. These highly electron-rich phosphines feature a polarized P-H bond, with computational studies revealing their dual nature as excellent hydride donors and superbasic phosphorus nucleophiles. Experimental investigations demonstrated their ability to transfer a hydride, proton, or hydrogen atom, depending on the reaction partner, as well as their reactivity in hydrophosphination reactions. The hydrophosphination of nonactivated alkynes proceeded under mild, metal-free conditions, yielding alkenylphosphine intermediates that partly rearranged into azaphosphole heterocycles.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.